Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.
about
A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humansAssociating Changes in the Immune System with Clinical Diseases for Interpretation in Risk AssessmentAssociations Between Selected Xenobiotics and Antinuclear Antibodies in the National Health and Nutrition Examination Survey, 1999-2004Structural equation modeling of immunotoxicity associated with exposure to perfluorinated alkylatesAntibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates.Perfluorinated Alkyl Substances: Emerging Insights Into Health Risks.Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years.Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds.Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults.Evaluation of the immunomodulatory effects of 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in C57BL/6 mice.Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting.Significance thresholds for the assessment of contaminated groundwater: perfluorinated and polyfluorinated chemicals.Delayed discovery, dissemination, and decisions on intervention in environmental health: a case study on immunotoxicity of perfluorinated alkylate substancesRubella immunity and serum perfluoroalkyl substances: Sex and analytic strategy
P2860
Q28072372-FCC372C2-283B-414C-98CB-4D2D66565902Q28388987-55336AD4-112F-4058-985A-C0F808325EA7Q28392083-D6FEEAF0-CA2A-4168-BE92-C55473FA899FQ35806933-5608AB87-89A0-4317-8B5B-88197D298B99Q36539348-A35B38AD-2B8C-4D7B-B020-84DE0862F895Q38530449-F58217D6-DD0B-4FF9-A1EB-712BF2DC4918Q38626231-13656157-1B7D-4A49-9E1E-120B825F0BADQ38657669-9889CDA3-0134-4CB1-9B3C-F209507A03E9Q40743240-D2ED8E08-929C-4059-BDFD-820371194A6FQ47881943-0C1EFCC3-B3DF-40F1-A687-0C6E77EDC471Q51063513-8B4DAC31-8918-4FA5-B1AE-FF314268A11FQ55278829-94CA281C-8AA8-45E9-8B6F-85AA3066C976Q56795452-92930C38-847A-432F-83ED-CA51CBB6C522Q58701478-F05BD0C0-8FFA-49B2-9359-B049E84410E9
P2860
Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Influenza vaccine response in ...... and perfluorooctanesulfonate.
@ast
Influenza vaccine response in ...... and perfluorooctanesulfonate.
@en
type
label
Influenza vaccine response in ...... and perfluorooctanesulfonate.
@ast
Influenza vaccine response in ...... and perfluorooctanesulfonate.
@en
prefLabel
Influenza vaccine response in ...... and perfluorooctanesulfonate.
@ast
Influenza vaccine response in ...... and perfluorooctanesulfonate.
@en
P2093
P2860
P356
P1476
Influenza vaccine response in ...... and perfluorooctanesulfonate.
@en
P2093
Claire Looker
Florence G Burleson
Gary R Burleson
Michael I Luster
Tony Fletcher
Victor J Johnson
P2860
P356
10.1093/TOXSCI/KFT269
P577
2013-11-27T00:00:00Z